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Abstract
Objectives—We assessed the willingness of gay and bisexual men, who have high rates of anal
cancer that might be prevented through regular screening, to receive anal Papanicolaou tests.
Methods—We surveyed a national sample of men aged 18 to 59 years who self-identified as gay
(n=236) or bisexual (n=70).
Results—Most respondents were willing to accept free screening (83%), but fewer would pay for
the test (31%; McNemar's χ2=158.02; P<.001). Willingness to pay for screening was higher among
men who reported greater worry about getting anal cancer (OR [odds ratio]=1.70; 95% confidence
interval [CI]=1.06, 2.72), higher perceived likelihood of anal cancer (OR=1.88; 95% CI=1.18, 2.99),
and higher income (OR=2.17; 95% CI=1.18, 3.98), in adjusted analyses. Only 33% (17 of 51) of
HIV-positive respondents, who have the highest risk for anal cancer, had received anal Papanicolaou
tests.
Conclusions—Anal cancer screening was highly acceptable to gay and bisexual men, although
cost was a major barrier. Efforts to reduce anal cancer disparities should target beliefs about anal
cancer and barriers to anal Papanicolaou testing in this population.
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Rates of anal cancer among men have nearly doubled over the past 3 decades in the United
States, making it an increasingly important public health concern.1 The observed increase in
anal cancer is a particular concern for gay and bisexual men, who are at substantially greater
risk for the disease than are heterosexual men.2 Furthermore, the risk of anal cancer is much
higher among HIV-positive men who have sex with men than it is among HIV-negative men
who have sex with men.3 The incidence of anal cancer among HIV-positive gay and bisexual
men may be up to 10 times greater than are current rates of cervical cancer among women in
the United States.4
In addition to HIV infection, risk factors for anal cancer include receptive anal intercourse, a
high number of lifetime sexual partners, rectal drug use, smoking, and certain sexually
transmitted infections, including human papillomavirus (HPV).2,5–8 These factors may help
explain the high rates of anal cancer observed among gay and bisexual men, because this
population has been shown to have high rates of risky sexual behavior (including receptive
anal intercourse with multiple partners), smoking and other drug use, and sexually transmitted
infections (including HPV infection).6,9–13
Research indicates that HPV may cause most anal cancers.4,5,8 A systematic review found that
HPV DNA was present in more than 70% of anal cancer cases, with HPV type 16 being the
most common.14 HPV DNA is found in 97.7% of anal tumors in men who are not exclusively
heterosexual.5 If approved for use in males, HPV vaccination may offer substantial protection
against anal cancer for males.4 However, HPV vaccination against oncogenic HPV types 16
and 18 is unlikely to prevent all anal cancers.14 Furthermore, many gay and bisexual men who
have initiated sexual activity may already be infected with HPV by the time they present for
vaccination. Thus, anal cancer screening could play a role in anal cancer prevention for gay
and bisexual men, regardless of whether they receive HPV vaccination.
Statistical models suggest that regularly screening gay and bisexual men for anal cancer
through anal Papanicolaou (Pap) testing (also called anal cytology) would increase life
expectancy similarly to other accepted prevention measures, such as cervical cancer screening,
and would be cost effective.15 Cost-effectiveness analyses suggest screening HIV-positive gay
and bisexual men annually16 and HIV-negative gay and bisexual men every 2 to 3 years.15
Although no national organizations yet offer guidelines for screening with anal Pap tests, the
Gay and Lesbian Medical Association encourages gay and bisexual men to talk with their health
care providers about anal cancer.17 The absence of national screening guidelines may be a
reason that health insurance reimbursements for anal cancer screening tests are limited.18
Studies of anal cancer screening behavior have focused on low rates of uptake and intentions,
19, 20 but they have not examined many constructs known to motivate other screening
behaviors, such as worry and perceived risk, that could help inform future intervention
programs. We examined beliefs of gay and bisexual men about anal cancer and anal cancer
screening, as well as correlates of willingness to receive anal Pap tests. In exploratory analyses,
we also examined whether HIV-positive gay and bisexual men, who are at especially high risk
for anal cancer, differed from HIV-negative gay and bisexual men in these beliefs and attitudes.
Methods
In January 2009, we interviewed men aged 18 to 59 years who were members of an existing
national panel of US households maintained by Knowledge Networks (Menlo Park, CA),
oversampling for our study men who self-identified as gay or bisexual. Knowledge Networks
identified panel members through list-assisted, random-digit dialing. Panel members received
free Internet access or small cash payments for completing multiple Internet-based surveys
each month.
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Of 874 men invited to participate in our study, 609 (70%) completed the online survey.21 We
did not ask heterosexual participants about anal cancer screening, because their risk of anal
cancer is much lower than that of gay and bisexual men and the cost-effectiveness of anal
cancer screening has not yet been examined for heterosexual men.2,5,22 We report data from
306 men who self-identified as either gay or bisexual. We excluded 12 men whose sexual
orientation we could not definitively categorize as either gay or bisexual. Most men in the final
sample self-identified as gay (77%) and were HIV negative (83%; Table 1). Their mean age
was 46.4 years (SD=9.0). Most were non-Hispanic White (81%), had college degrees (56%),
reported annual household incomes of $60000 or higher (60%), had health insurance (86%),
and lived in urban areas (93%). Approximately one half were living with a partner or were
married (48%); similar percentages of gay (47%) and bisexual (50%) men reported this type
of relationship.
Measures
The survey is available online at http://www.unc.edu/∼ntbrewer/hpv.htm. We drew on our
previous work on HPV-related diseases23–25 and others' work on anal Pap tests19, 20 in
developing our survey items. We cognitively tested the survey with 28 gay and bisexual men
and further refined it with 8 additional men prior to beginning the study.
Anal cancer—The survey first presented basic information about anal cancer, because pilot
testing showed that men had low familiarity with the disease: “Anal cancer forms in the tissues
of the anus. The anus is the opening of the rectum (last part of the large intestine) to the outside
of the body. Anal cancer is different from colon cancer and rectal cancer.” The survey then
assessed perceived knowledge about anal cancer, perceived severity of anal cancer, concern
about anal cancer, perceived likelihood of getting anal cancer, and how men thought HIV
affects the chances of getting anal cancer.
Anal Pap tests—We measured awareness of anal Pap tests and then presented basic
information about this test, because pilot testing showed that most men were unfamiliar with
the procedure. The survey then assessed history of anal Pap testing by asking men when their
most recent test occurred, whether they had ever tried unsuccessfully to get an anal Pap test
(including the main reason they were unsuccessful), where they would go to get an anal Pap
test if they decided to get one, barriers that they believed would prevent them from getting an
anal Pap test, perceived effectiveness of anal Pap testing, whether anal Pap testing is only
needed for people who have anal intercourse, how often men who have sex with men should
get an anal Pap test, and whether they thought doctors recommend anal Pap tests for men who
have sex with men.
Willingness—We assessed how willing men would be to get an anal Pap test (1) if it were
free, and (2) if it cost $150 out of pocket. Response options for willingness items were
“definitely not willing,” “probably not willing,” “not sure,” “probably willing,” and “definitely
willing.” We recoded responses into 2 categories, willing (definitely or probably willing) and
not willing (all other responses).
Demographic characteristics—Men indicated their sexual orientation as “gay or
homosexual [attracted to men]” or “bisexual [attracted to men and women],” as well as their
age, race/ethnicity, education, income, health insurance status, urbanicity (according to
Metropolitan Statistical Area criteria26), and relationship status. The survey also assessed men's
sexual and medical history, including history of sexually transmitted infections, anal or penile
lesions, and oral, anal, and penile cancer (cancer at these anatomic sites shows consistent
associations with high-risk HPV types27).
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We used McNemar's test to compare willingness to receive an anal Pap test if it were free or
cost $150. We used logistic regression to examine bivariate correlates of willingness to receive
an anal Pap test if it cost $150. We chose this willingness measure as the primary study outcome,
instead of willingness if testing were free, because in current clinical practice, reimbursement
for anal screening tests is often limited.18 We entered statistically significant bivariate
correlates (P< .05) into a multivariate model.
Post hoc exploratory analyses compared HIV-positive gay and bisexual men to HIV-negative
gay men and HIV-negative bisexual men on variables that analyses identified as bivariate
correlates of willingness. These post hoc analyses used 1-way analysis of variance for
continuous variables and logistic regression for categorical variables. We analyzed data with
SPSS version 16.0 (SPSS Inc, Chicago, IL) and Intercooled Stata version 10.1 (StataCorp LP,
College Station, TX). All statistical tests were 2-tailed, with a critical α of 0.05.
Results
Only 23% (71 of 306) of gay and bisexual men had heard of anal Pap tests prior to the survey.
Even fewer men reported ever having received an anal Pap test (14%; 44 of 306). Five men
indicated that they had tried to get an anal Pap test but were unsuccessful because their doctor
or health care provider did not usually give the test (n=2), their doctor or health care provider
told them they did not need an anal Pap test (n=2), or their doctor or health care provider told
them the cost of doing the test was too high to justify doing it (n=1).
Willingness to Receive an Anal Pap Test
Fewer than one third (31%; 95 of 306) of men were willing to get an anal Pap test if it cost
$150. A much larger percentage (83%; 255 (McNemar's χ2=158.02; P< .0 01). To receive anal
Pap testing in the future, most men indicated they would go to their primary care provider
(83%; 252 of 305), a gay health center (7%; 20 of 305), or a sexual health clinic (5%; 14 of
305). The most common reasons men reported for unwillingness to get an anal Pap test, even
if a local doctor or clinic performed them, were cost (39%; 120 of 306), not knowing enough
about the test (28%; 87 of 306), embarrassment about requesting or getting the test (13%; 41
of 306), concern about the test being inaccurate (7%; 20 of 306), and concern that testing
information would be recorded in medical records (5%; 16 of 306).
Bivariate analyses found that men were more willing to get anal Pap tests if they reported
greater perceived knowledge about anal cancer, greater worry about getting anal cancer, or
higher perceived likelihood of developing anal cancer (all, P<.05; Table 2). Other correlates
of willingness included being aware of anal Pap testing prior to our study, having had an anal
Pap test, knowing the best frequency for anal Pap testing (1 to 3 years, according to cost-
effectiveness modeling), not believing anal Pap tests are only necessary for people who have
anal intercourse, and having had a digital rectal exam. Men were also more willing to undergo
anal Pap testing if they were gay, were HIV positive, or had an annual household income of
$60000 or higher. Men were less willing to undergo anal Pap testing if they had not disclosed
their sexual behavior with men to their primary health care provider.
Multivariate analyses (Table 3) found that men were more willing to get an anal Pap test if
they reported greater worry about getting anal cancer (odds ratio [OR]=1.70; 95% confidence
interval [CI]=1.06, 2.72). We dichotomized worry to characterize this association, although
our regression analyses examined both worry and perceived likelihood as continuous. Men
who worried a moderate amount or quite a lot about anal cancer were more likely to report a
willingness to get an anal Pap test (70%; 21 of 30) than were respondents who were not at all
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or a little worried (27%; 74 of 276). Participants who perceived a greater likelihood of
developing anal cancer (OR=1.88; 95% CI=1.18, 2.99) were more willing to get an anal Pap
test. More men who perceived their chances of getting anal cancer as moderate, high, or certain
(48%; 38 of 79) than men who perceived their chance as low or none (25%; 57 of 227) were
willing to get an anal Pap test. Men who reported household incomes of $60000 or more were
more willing than were those who reported earning less to get an anal Pap test (OR=2.17; 95%
CI = 1.18, 3.98).
Sexual Orientation and HIV Status
Exploratory analyses examined differences between HIV-positive gay and bisexual men, HIV-
negative gay men, and HIV-negative bisexual men (Table 4). Few HIV-negative gay and
bisexual men reported ever having received an anal Pap test (11%; 27 of 255). Of HIV-negative
gay and bisexual men who had received an anal Pap test, 89% (24 of 27) reported that their
most recent test was within the past 3 years, the cost-effective testing interval for this
population.15 Only 33 % (17 of 51) of HIV-positive gay and bisexual men had received an anal
Pap test. Of these men, only 53% (9 of 17) reported that their most recent test was within the
previous year, the cost-effective interval for this population.16
HIV-positive gay and bisexual men were more likely than were HIV-negative gay and bisexual
men to have disclosed their sexual behavior with men to their primary health care provider, to
have been aware of anal Pap testing before completing the survey, to have had an anal Pap test,
and to report higher levels of worry about getting anal cancer. HIV-positive gay and bisexual
men also reported greater perceived knowledge of anal cancer and perceived greater likelihood
of developing anal cancer than did HIV-negative bisexual men. HIV-negative gay men were
more likely than were HIV-negative bisexual men to have disclosed their sexual behavior with
men to their primary health care provider and to have been aware of anal Pap testing before
completing our survey.
Discussion
Although gay and bisexual men have notably high rates of anal cancer, it is promising that
potential benefits of anal cancer screening for these men are comparable to observed benefits
of cervical cancer screening for women.15 However, only 1 in 7 gay and bisexual men in our
national sample had received an anal Pap test, a rate comparable to those measured in previous
studies conducted primarily among convenience samples of gay and bisexual men (11% –14
%). 19, 20 Furthermore, only one third of HIV-positive gay and bisexual men in our study
reported having had an anal Pap test, with even fewer indicating their most recent test was
within the past year, the cost-effective screening interval for this population.16 It is encouraging
that more than half of HIV-positive gay and bisexual men were willing to pay for anal Pap
tests in the future.
We identified important modifiable beliefs associated with willingness to get anal cancer
screening tests that have not been extensively studied among gay and bisexual men.
Multivariate analysis revealed that men who reported greater worry about getting anal cancer
and higher perceived likelihood of getting anal cancer were more willing to undergo future
anal Pap testing. Many health behavior theories posit that risk perception prompts protective
health behaviors, a proposition that is well supported for many different behaviors, including
cancer screening.28–30 Some health behavior theorists also suggest that affect, such as worry,
is important to motivating health behavior, including cancer screening.31, 32 Our findings
support these relationships.
HIV status may affect gay and bisexual men's attitudes and beliefs about anal Pap testing. HIV-
positive participants were more likely than were HIV-negative participants to be aware of anal
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Pap testing, to report having had an anal Pap test, and to report more worry about getting anal
cancer. Previous research also has found greater concern about anal cancer among HIV-positive
men who have sex with men.19 Because HIV-positive gay and bisexual men are at higher risk
of anal cancer, these differences are unsurprising.
Gay and bisexual men differed in their knowledge, beliefs, and behaviors related to anal Pap
testing. For example, gay men were more likely than were bisexual men to have heard of anal
Pap testing and to have disclosed their sexual orientation to their primary health care provider.
Gay men were also more willing to undergo anal Pap testing regardless of cost than were
bisexual men (in bivariate analyses). Interventions to increase anal cancer screening may need
to be tailored to differing beliefs of gay and bisexual men.
Implications for Practice
Awareness and cost are substantial barriers to gay and bisexual men initiating anal cancer
screening. Few men had heard of anal Pap tests, making awareness a straightforward target for
campaigns to boost screening. Less easily addressed is the large impact that cost had on
willingness to get anal Pap tests. Half of our sample was willing to get anal Pap tests only if
they did not have to pay out of pocket. Men with lower incomes were also less willing to pay
for anal Pap tests. Our results for income were similar to those previously reported: uninsured
men who have sex with men were less likely to seek anal Pap testing.19 Furthermore, abnormal
anal Pap tests may entail substantial additional costs for follow-up and treatment that may not
be covered by health insurance. Education campaigns may be beneficial, but they must be
accompanied, or preceded, by policy changes that ensure that anal Pap testing and follow-up
are more affordable and widely available.
Most men indicated that they would go to their primary care providers if they wanted to get
anal Pap tests. This finding suggests that primary care physicians should be educated about the
importance of anal cancer screening for HIV-negative and HIV-positive gay and bisexual men.
No published data we are aware of address whether doctors discuss anal cancer screening with
gay and bisexual men patients or perform such tests.33 In our study, 5 men reported being
unsuccessful in obtaining an anal Pap test. If primary care physicians are to be the medical
home for gay and bisexual men, they may require additional training about anal cancer and
anal Pap tests to meet this need. For men who do not have access to clinicians who can provide
anal Pap tests, home screening by mailed tests may be a viable alternative.34
Another important issue is the availability of clinicians knowledgeable and skilled in the
follow-up of abnormal anal cytology results, including high-resolution anoscopy and biopsy.
22 Future research is needed to address these issues, as well as the acceptability of follow-up
tests, among gay and bisexual men.
More than 25% of our respondents indicated that they had not disclosed that they have sex with
men to their health care providers. This finding indicates a greater need for health care providers
to create environments that facilitate patient disclosure of their sexual behaviors to allow
providers to identify men most likely to benefit from anal cancer prevention services. The Gay
and Lesbian Medical Association recommends providing this type of medical environment.
35 For example, it encourages providers to post nondiscrimination statements in their clinics
and to use gender-neutral language about sexual or relationship partners.35 When taking a
sexual history, practitioners should ask patients if they have ever been sexually active with
men, women, or both.36 By discussing sexual history with all adult male patients, primary
health care providers will be able to identify gay and bisexual men who are at high risk of anal
cancer and to discuss anal cancer screening with them.
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Our national sample yielded a high participation rate, enough bisexual men to enable
exploration of differences from other participants, and enough respondents to enable
examination of many novel correlates of willingness to receive an anal Pap test. We focused
on populations at higher risk for anal cancer than the general population.
Limitations included a cross-sectional design and reliance on self-report for screening history.
We also did not assess condom use or the frequency of receptive anal intercourse. The main
outcome, willingness to obtain an anal Pap test, may have overstated behavior that we would
observe if the test were more easily obtained; hypothetical statements can fail to anticipate
barriers to action. Additional costs of follow-up and potential treatment required by abnormal
screening tests could also affect willingness and are a topic for future research. Although our
sample was drawn from a study panel known to closely resemble the US population,37 most
participants were non-Hispanic Whites, had high socioeconomic status, and resided in urban
areas. The generalizability of the findings to other gay and bisexual men is not yet known. The
financial and informational barriers to anal Pap screening that we observed may be even more
prevalent among a more diverse sample of gay and bisexual men.
Conclusions
Few gay and bisexual men in our sample had undergone anal Pap testing or even heard of it.
This is a concern for this high-risk group and especially for those who are HIV positive.
Correlates of willingness to undergo anal cancer screening offer potentially modifiable targets
for future interventions designed to increase anal Pap testing among this high-risk population.
Cost strongly affected men's willingness to undergo anal Pap tests, suggesting the need for
policy changes that make anal cancer screening more affordable.
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Table 1
Demographic Characteristics of Participants in Survey of Gay and Bisexual Men's
Knowledge and Attitudes Toward Anal Cancer Screening: United States, January 2009






 Non-Hispanic White 247 (81)




 No college degree 136 (44)
 College degree 170 (56)
Annual household income, $
 <60 000 122 (40)











 Not living with partner and not married 160 (52)




Ever diagnosed with cancer (oral, anal, penile) or lesions (anal, penile)
 No 301 (98)
 Yes 5 (2)
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Table 2
Bivariate Correlates of Willingness to Get an Anal Papanicolaou Test Among Gay and
Bisexual Men: United States, January 2009
Not Willing (n=211),
Mean (SD) or No. (%)
Willing (n=95), Mean
(SD) or No. (%) OR (95% CI)
Anal cancer and screening
Perceived knowledge of anal cancera 1.36 (0.61) 1.84 (0.90) 2.32** (1.65, 3.25)
Worry about anal cancerb 1.29 (0.59) 1.83 (0.96) 2.47** (1.76, 3.46)
Perceived severity of anal cancerb 3.58 (0.76) 3.64 (0.68) 1.12 (0.80, 1.58)
Belief that HIV status affects likelihood of anal cancerc 2.84 (0.30) 2.77 (0.41) 0.61 (0.31, 1.20)
Perceived likelihood of anal cancerd 2.09 (0.62) 2.43 (0.68) 2.23** (1.51, 3.30)
Perceived effectiveness of anal Pap teste 2.18 (0.84) 2.06 (0.81) 0.83 (0.62, 1.13)
Belief that only people who have anal intercourse need anal Pap
testse
3.53 (1.11) 3.81 (1.15) 1.26* (1.01, 1.58)
Awareness of anal Pap test
 No (Ref) 175 (74) 60 (26) 1.00
 Yes 36 (51) 35 (49) 2.84** (1.64, 4.92)
Had anal Pap test
 No (Ref) 192 (73) 70 (27) 1.00
 Yes 19 (43) 25 (57) 3.61** (1.87, 6.96)
Unsuccessfully attempted to get anal
 Pap test
 No (Ref) 209 (69) 92 (31) 1.00
 Yes 2 (40) 3 (60) 3.41 (0.56, 20.74)
Belief that doctors recommend anal Pap tests for men who have
sex with men
 No (Ref) 40 (67) 20 (33) 1.00
 Yes 72 (64) 40 (36) 1.11 (0.57, 2.15)
Did not know 99 (74) 35 (26) 0.71 (0.37, 1.37)
Knew cost-effective frequency for anal Pap testing (1–3 y)
 No (Ref) 123 (75) 40 (25) 1.00
 Yes 88 (62) 55 (38) 1.92* (1.18, 3.14)
Had digital rectal exam
 No (Ref) 64 (81) 15 (19) 1.00
 Yes 147 (65) 80 (35) 2.32* (1.24, 4.34)
Sexual identity and behavior
Sexual orientation
 Bisexual (Ref) 58 (83) 12 (17) 1.00
 Gay 153 (65) 83 (35) 2.62* (1.33, 5.16)
Disclosed sexual behavior with men to primary care provider
 Yes (Ref) 116 (62) 70 (38) 1.00
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Not Willing (n=211),
Mean (SD) or No. (%)
Willing (n=95), Mean
(SD) or No. (%) OR (95% CI)
 Not applicable/missing 33 (85) 6 (15) 0.30* (0.12, 0.76)
 No 62 (77) 19 (23) 0.51* (0.28, 0.91)
Age at first sexual intercourse (oral, anal, or vaginal), y
 <16 (Ref) 72 (67) 36 (33) 1.00
 ≥ 16 139 (70) 59 (30) 0.85 (0.52, 1.40)
No. of lifetime sexual partnersf
 ≤4 (Ref) 28 (80) 7 (20) 1.00
 ≥5 183 (68) 88 (33) 1.92 (0.81, 4.58)
No. of male partners (anal or oral intercourse) in past year
 ≤4 (Ref) 160 (71) 67 (29) 1.00
 ≥5 51 (65) 28 (35) 1.31 (0.76, 2.26)
Diagnosis of cancer (oral, anal, penile) or lesions (anal, penile)
 No (Ref) 209 (69) 92 (31) 1.00
 Yes 2 (40) 3 (60) 3.41 (0.56, 20.73)
HIV status
 Negative (Ref) 186 (73) 69 (27) 1.00
 Positive 25 (49) 26 (51) 2.80* (1.52, 5.18)
Other STI diagnosis
 No (Ref) 150 (72) 59 (28) 1.00
 Yes 61 (63) 36 (37) 1.50 (0.90, 2.50)
Demographic characteristics
Health insurance
 No (Ref) 35 (80) 9 (20) 1.00
 Yes 176 (67) 86 (33) 1.90 (0.87, 4.13)
Current smoker
 No (Ref) 158 (72) 61 (28) 1.00
 Yes 53 (61) 34 (39) 1.66 (0.99, 2.80)
Race/ethnicity
 Non-Hispanic White (Ref) 172 (70) 75 (30) 1.00
 Other 39 (66) 20 (34) 1.18 (0.64, 2.15)
Age, y
 50–59 (Ref) 83 (67) 40 (33) 1.00
 40–49 85 (69) 39 (31) 0.95 (0.56, 1.63)
 20–39 43 (73) 16 (27) 0.77 (0.39, 1.53)
Annual household income, $
 <60 000 (Ref) 94 (77) 28 (23) 1.00
 ≥60 000 117 (64) 67 (36) 1.92* (1.15, 3.23)
Education
 No college degree (Ref) 96 (71) 40 (29) 1.00
 College degree 115 (68) 55 (32) 1.15 (0.70, 1.87)
Urbanicity
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Not Willing (n=211),
Mean (SD) or No. (%)
Willing (n=95), Mean
(SD) or No. (%) OR (95% CI)
 Rural (Ref) 14 (70) 6 (30) 1.00
 Urban 197 (69) 89 (31) 1.05 (0.39, 2.83)
Relationship status
 Not living with partner and not married (Ref) 116 (73) 44 (27) 1.00
 Living with partner or married 95 (65) 51 (35) 1.42 (0.87, 2.30)
Note: CI = confidence interval; OR = odds ratio; Pap = Papanicolaou; STI = sexually transmitted infection.
a
On a 4-point scale: 1 (nothing at all), 2 (a little), 3 (a moderate amount), 4 (quite a lot).
b
On a 4-point scale: 1 (not at all), 2 (a little), 3 (a moderate amount), 4 (quite a lot).
c
On a 3-point scale: 1 (decreases chances), 2 (has no effect), 3 (increases chances).
d
On a 5-point scale: 1 (no chance), 2 (low chance), 3 (moderate chance), 4 (high chance), 5 (certain I will get anal cancer).
e
On a 5-point scale: 1 (strongly agree), 2 (somewhat agree), 3 (neither agree nor disagree), 4 (somewhat disagree), 5 (strongly disagree).
f
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Table 3
Multivariate Correlates of Willingness to Get an Anal Papanicolaou Test Among Gay and
Bisexual Men: United States, January 2009
OR (95% CI)
Perceived knowledge of anal cancer 1.38 (0.86, 2.21)
Worry about anal cancer 1.70* (1.06, 2.72)
Perceived likelihood of anal cancer 1.88* (1.18, 2.99)
Awareness of anal Pap test
 No (Ref) 1.00
 Yes 0.84 (0.37, 1.91)
Had anal Pap test
 No (Ref) 1.00
 Yes 2.15 (0.91, 5.09)
Knew cost-effective frequency for anal Pap testing (1–3 y)
 No (Ref) 1.00
 Yes 1.61 (0.91, 2.83)
Belief that only people who have anal intercourse need anal Pap tests 1.15 (0.89, 1.48)
Sexual orientation
 Bisexual (Ref) 1.00
 Gay 1.72 (0.74, 4.02)
Had digital rectal exam
 No (Ref) 1.00
 Yes 1.71 (0.83, 3.52)
Disclosed sexual behavior with men to primary care provider
 Yes (Ref) 1.00
 Not applicable/missing 0.67 (0.23, 1.96)
 No 0.76 (0.36, 1.61)
HIV status
 Negative (Ref) 1.00
 Positive 1.44 (0.67, 3.09)
Annual household income, $
 <60000 (Ref) 1.00
 ≥60000 2.17* (1.18, 3.98)
Note. CI=confidence interval; OR=odds ratio; Pap=Papanicolaou. Multivariate model contained only the variables displayed in this table.
*
P <.05.
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Table 4
Effects of HIV Status and Sexual Orientation on Bivariate Correlates of Willingness to Get
an Anal Papanicolaou Test Among Gay and Bisexual Men: United States, January 2009
HIV-Positive Participantsa (n =
51), Mean (SD) or No. (%)
HIV-Negative Gay
Participants (n = 186),
Mean (SD) or No. (%)
HIV-Negative Bisexual
Participants (n = 69),
Mean (SD) or No. (%)
Perceived knowledge of anal cancerb 1.76 (0.97) 1.51 (0.74) 1.33c (0.50)
Worry about anal cancerd 1.80 (1.06) 1.38e (0.67) 1.40c (0.69)
Perceived likelihood of anal cancerf 2.39 (0.80) 2.19 (0.57) 2.08c (0.73)
Belief that only people who have anal
intercourse need anal Pap testsg
3.76 (1.19) 3.68 (1.07) 3.33 (1.20)
Awareness of anal Pap test
 No 23 (45) 149e,h (80) 63c (91)
 Yes 28 (55) 37 (20) 6 (9)
Had anal Pap test
 No 34 (67) 164e (88) 64c (93)
 Yes 17 (33) 22 (12) 5 (7)
Knew cost-effective frequency for anal Pap
testing (1-3 y)
 No 22 (43) 103 (55) 38 (55)
 Yes 29 (57) 83 (45) 31 (45)
Had digital rectal exam
 No 11 (22) 46 (25) 22 (32)
 Yes 40 (78) 140 (75) 47 (68)
Disclosed sexual behavior with men to primary
care provider
 Noi 4 (8) 62e,h (33) 54c (78)
 Yes 47 (92) 124 (67) 15 (22)
Annual household income, $
 <60 000 21 (41) 68 (37) 33 (48)
 ≥ 60 000 30 (59) 118 (63) 36 (52)
Note: Pap = Papanicolaou. Table contains variables bivariately associated with willingness to receive an anal Pap test. Sexual orientation and HIV
status were not examined because they were used to create the 3 comparison groups.
a
HIV-positive cohort comprised 50 gay men and 1 bisexual man.
b
On a 4-point scale: 1 (nothing at all), 2 (a little), 3 (a moderate amount), 4 (quite a lot).
c
Difference between HIV-positive participants and HIV-negative bisexual men, P<.05.
d
On a 4-point scale: 1 (not at all), 2 (a little), 3 (a moderate amount), 4 (quite a lot).
e
Difference between HIV-positive participants and HIV-negative gay men, P<.05.
f
On a 5-point scale: 1 (no chance), 2 (low chance), 3 (moderate chance), 4 (high chance), 5 (certain I will get anal cancer).
g
On a 5-point scale: 1 (strongly agree), 2 (somewhat agree), 3 (neither agree nor disagree), 4 (somewhat disagree), 5 (strongly disagree).
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h
Difference between HIV-negative gay and bisexual men, P<.05.
i
Included not applicable/missing (n = 39).
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